CD8A and vitiligo: Taken together, an effective treatment to limit vitiligo progression and recurrence needs to improve i) the EAS enzymes (i.e., GPx, TrxR, and CAT); ii) the function and quality of mitochondria structure in melanocytes and CD8+ T cells; and iii) change the profile of the immune system.